Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2007
06/06/2007EP1792623A1 Use of extracts and constituents of leontopodium as enhancers of cholinergic function
06/06/2007EP1792617A1 Treatment of dyskinesia
06/06/2007EP1792615A1 Method of screening for a visceral pain inhibitor
06/06/2007EP1792610A2 Sustained release bioadhesive therapeutic systems
06/06/2007EP1791949A2 Methods and materials relating to enhanced production of dopamine neurons
06/06/2007EP1791904A2 Method of treating organophosphorous poisoning
06/06/2007EP1791854A2 Methods of treating disorders having a component of mercury toxicity
06/06/2007EP1791841A1 2-substituted-1-deaza purine derivatives with adenosine receptor modulating activity
06/06/2007EP1791840A1 Substituted bicyclic imidazo-3-ylamine compounds
06/06/2007EP1791818A1 Hydrazone derivatives and their use as beta secretase inhibitors
06/06/2007EP1791813A1 Pentafluorosulfanylphenyl-substituted benzoylguanidines, method for the production thereof, their use as a medicament or diagnostic agent, and a medicament containing these compounds
06/06/2007EP1791809A1 Substituted aniline derivatives
06/06/2007EP1791806A2 Amine compounds and inhibiting neurotransmitter reuptake
06/06/2007EP1791600A1 Combination of organic compounds
06/06/2007EP1791599A1 Combination of a 5-ht(1) receptor agonist and an alpha-2-delta ligand for the treatment of migraine
06/06/2007EP1791552A2 Protein a compositions and methods of use
06/06/2007EP1791541A2 Methods of treating mood disorders using benzisoxazole containing diazabicyclic compounds
06/06/2007EP1791540A2 Methods of treating cognitive disorders using pyridyloxymethyl and benzisoxazole azabicyclic derivatives
06/06/2007EP1791537A1 3-arylthioindole-2-carboxamide derivatives and analogs thereof as inhibitors of casein kinase i
06/06/2007EP1680400B1 Derivatives of n-[ phenyl(pyrrolidine-2-yl)methyl]benzamide and n-[ (azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics
06/06/2007EP1613297B1 Therapeutic patch with polysiloxane matrix comprising capsaicin
06/06/2007EP1542666B1 Modafinil pharmaceutical compositions
06/06/2007EP1489083B1 Fused bicyclic pyridine derivative as tachykinin receptor antagonist
06/06/2007EP1487998B1 Methods for diagnosing and treating schizophrenia
06/06/2007EP1406660B1 Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor
06/06/2007EP1402034B1 Identification of ses-1 and the uses of the same
06/06/2007EP1378267B1 Use of flumazenil to produce a medicament for the treatment of cocaine dependency
06/06/2007EP1363874B1 Tryptase inhibitors
06/06/2007EP1283699B1 Injectable suspensions having improved injectability properties
06/06/2007EP1011711B1 Synergistic effects of op/bmp morphogens and gdnf/ngf neurotrophic factors
06/06/2007EP0954317B1 Use of 7 apha-substituted steroids to treat neuropsychiatric disorders
06/06/2007EP0839039B2 Paroxetine controlled release compositions
06/06/2007CN1976935A Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
06/06/2007CN1976934A Alkyl substituted indoloquinoxalines
06/06/2007CN1976928A Indolylalkylamine metabolites as 5-hydroxytryptamine-6 ligands
06/06/2007CN1976919A Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto
06/06/2007CN1976917A Pyridine derivatives of alkyl oxindoles functioning as active substance against 5-HT7 receptor
06/06/2007CN1976916A Selected CGRP - antagonists, process for preparing them and their use as pharmaceutical compositions
06/06/2007CN1976906A Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors
06/06/2007CN1976722A 活性物质联合 Active substances combined
06/06/2007CN1976682A Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active component
06/06/2007CN1974574A Novel tricyclic spiropiperidines or spiropyrrolidines
06/06/2007CN1974570A Fused pyrrolocarbazoles against inflammation
06/06/2007CN1974558A (+)-Meptazinol diligand derivative and/or its salt and the prepn process
06/06/2007CN1973917A Electrothermal cap for dredging cerebral meridian and its making process
06/06/2007CN1973895A Medicine for sober-up and treating acute alcoholism and its prepn
06/06/2007CN1973893A Externally applied medicine for treating neck and waist arthrosis
06/06/2007CN1973892A Addiction eliminating ointment
06/06/2007CN1973890A Medicine prepn for promoting intelligence growth and nourishing brain and its prepn process
06/06/2007CN1973889A Insomnia treating Chinese medicine
06/06/2007CN1973887A Medicine composition and its prepn
06/06/2007CN1973872A Medicine for nourishing Yin, invigorating kidney, strengthening physique and nourishing brain and its prepn
06/06/2007CN1973869A Natural beverage liquid with sober-up function and its prpen
06/06/2007CN1973851A Application of astragalus root and astragalus polysaccharide in preparing medicine for treating neurodegenerative diseases
06/06/2007CN1973847A Nasal liquid medicine for treating headache and its prepn process
06/06/2007CN1973840A Long acting slow releasing drug addiction eliminating prepn and its prepn process and use
06/06/2007CN1319987C Gamma-secretase inhibitors
06/06/2007CN1319974C Novel polymorph of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-alpha]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
06/06/2007CN1319973C Piperidine derivatives
06/06/2007CN1319968C Compositions useful as inhibitors of GSK-3
06/06/2007CN1319963C Dihydrothiaphenanthrenecarbonylguanidines: composition, process of making, and use as medicament or diagnostic aid
06/06/2007CN1319962C 3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia
06/06/2007CN1319958C Phenyl-piperazine derivatives as serotonin reuptake inhibitors
06/06/2007CN1319950C 3-substituted-4-pyrimidone derivatives
06/06/2007CN1319945C Secondary amino anilinic piperidines as MCH1 antagonists and uses thereof
06/06/2007CN1319561C Medicine for treating Parkinson's disease
06/06/2007CN1319556C Oral Chinese-medicine preparation for treating neuropathic pain
06/06/2007CN1319548C Chinese medicine health tonic for raising antisenility capacity and improving memory
06/06/2007CN1319539C Medicinal composition with synergetic function
06/06/2007CN1319532C Use of N-(indolecarbonyl-)piperazine derivatives
06/06/2007CN1319530C Neurotrophic factor production promoter
06/06/2007CN1319529C 1H-1,2,4-triazole-3-carboxamide derivatives as cannabinoid-CB receptor ligands
06/05/2007USRE39680 Sleep disorders associated with 5-HT2A serotonin receptor modulation; antagonists or agonists
06/05/2007US7227023 Quinoline 3-amino chroman derivatives
06/05/2007US7227022 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase
06/05/2007US7227020 protein kinase inhibitors; asthma, psoriasis, antiinflammatory agents; inflammatory bowel disorders
06/05/2007US7226950 Sodium channel modulators
06/05/2007US7226948 Treatment of neurodegenerative conditions with nimesulide
06/05/2007US7226945 Estrogen receptor-β ligands
06/05/2007US7226933 3-[(1-benzyl-piperidin-4-yl)-(4-diethylcarbamoyl-phenyl)-amino]-benzamide used as opiod receptor agonists having improved pharmacokinetic, bioavailability, stability and/or lower toxicity; analgesisc; anxiolytic agents
06/05/2007US7226930 Phosphodiesterase 4 inhibitors
06/05/2007US7226926 8-fluoroimidazo 1,2-a pyridine derivatives as ligands for GABA receptors
06/05/2007US7226924 Substituted 3,4-dihydro-pyrimido[1,2a]pyrimidines and 3,4-dihydro-pyrazino[1,2a]pyrimidines, and methods for their preparation and use
06/05/2007US7226917 Derivatives of N-[phenyl(pyrrolidine-2-yl)methyl]benzamide and N-[(azepan-2-yl)phenylmethyl]benzamide, preparation, and use in treatment of schizophrenia
06/05/2007US7226914 Administering sulfated polysaccharide such as cellulose sulfate, dextran sulfate, dermatan sulfate, chondroitin sulfate, pentosan sulfate, fucoidin, mannan sulfate, dextrin sulfate, curdlan sulfate, chitin sulfate, heparin or heparin sulfate for therapy and prphylaxis of fungal infection
06/05/2007US7226785 A single-stranded oligonucleotide with a DNA domain having at least one mismatch with respect to genetic sequence to be altered
06/05/2007US7226758 glial derived neurotrophic factor (GDNF) isolated from serum-free growth conditioned medium of glioblastoma cells; for preventing and treating nerve damage and nerve related diseases such as Parkinson's disease; genetic engineering
06/05/2007CA2411671C Inhibitors of alpha l beta 2 mediated cell adhesion
06/05/2007CA2293836C Polymorphic form of a tachykinin receptor antagonist
06/05/2007CA2157586C Indoletetralins having dopaminergic activity
06/05/2007CA2143442C Dorsal tissue affecting factor and compositions
06/05/2007CA2125644C Pharmaceutical compositions containing the salts of s(+)-2-(4-isobutylphenyl)propionic acid with basic aminoacids
05/2007
05/31/2007WO2007062193A1 Heterocycle-substituted 3-alkyl azetidine derivatives
05/31/2007WO2007062119A1 Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity
05/31/2007WO2007062007A1 Beta-secretase modulators and methods of use
05/31/2007WO2007061978A1 Spirocyclic compounds as hdac inhibitors
05/31/2007WO2007061930A1 Beta-secretase modulators and methods of use
05/31/2007WO2007061880A1 Spirocyclic compounds as hdac inhibitors
05/31/2007WO2007061868A2 Treatment of stereotypic, self-injurious and compulsive behaviors using specific serotonin reuptake inhibitors and antagonists of nmda receptors
05/31/2007WO2007061670A1 Beta-secretase modulators and methods of use
1 ... 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 ... 1833